The Transgenic RNAi Project at Harvard Medical School: Resources and Validation

Area of Science:

• Genetics
• Molecular Biology
• Developmental Biology

Background:

• Large-scale functional studies are crucial for understanding gene function in complex organisms.
• Drosophila melanogaster serves as a powerful model organism for genetic research.

Purpose of the Study:

• To establish the Drosophila Transgenic RNAi Project (TRiP) for facilitating large-scale functional genomics in Drosophila.
• To develop efficient RNA interference (RNAi) vectors and create a comprehensive, genome-scale collection of RNAi stocks.
• To validate RNAi lines and provide accessible resources for researchers.

Main Methods:

• Development of efficient RNAi vectors for broad tissue expression.
• Generation of a genome-scale collection of Drosophila RNAi stocks.
• Validation of RNAi lines using quantitative reverse transcription PCR (RT-qPCR) and phenotypic analyses.
• Creation of web-based tools and resources for stock identification and data retrieval.

Main Results:

• The TRiP collection currently comprises 11,491 RNAi lines, covering 71% of Drosophila genes.
• Validation data, including RT-qPCR and phenotypic information, are available on the RSVP website.
• RNAi stocks are distributed through established international stock centers.

Conclusions:

• The TRiP initiative provides a valuable, large-scale resource for Drosophila functional genomics.
• The developed tools and validated RNAi stocks significantly enhance the capacity for systematic gene function studies in Drosophila.
• Accessibility of validated RNAi lines and data promotes efficient research in fly genetics.